medigraphic.com
Anales de la Sociedad Mexicana de Oftalmología y Archivos de la Asociación Para Evitar la Ceguera en México

2005, Number 6

<< Back Next >>

Rev Mex Oftalmol 2005; 79 (6)

Alcohol injection treatment of essential blepharospasm, Meige syndrome and hemifacial spasm.

Lozano ED, Gómez VT

Language: Spanish
References: 13
Page: 296-300
PDF size: 70.28 Kb.


ABSTRACT

Alcohol (Ethanol) was injected as treatment to 14 patients, seven with Meige syndrome, five essential Blepharospasm and two with Hemifacial spasm, who rejected surgery and they were minimally responsive to psycopharmacos and botulinum toxin treatment; from Jan/01 to Jan/05 in the INNN. M.V.S. Average follow up was 11.6 months. The mean interval of relief spasm was 7.9 months. The injection technique used is illustrated; only transitory severe facial edema, no blepharoptosis either diplopia as a complication was observed.
The treatment was effective in virtually all patients.
The main advantage of this procedure are minimal local and no systemic side effects, low cost, longer interval of relief and technically simple.
Alcohol injection shows promise in this preliminary study.


REFERENCES

  1. 1. Harris W, Wright AD. Treatment of clonic spasm a) By alcohol Injection, b) nerve anastomosis. Lancet 1932; 1:657-62.

  2. 2. Walsh FB. Neurophthalmology 2° ed. William and Wilkins Co, 1957. 191-93.

  3. 3. Onishi ET y col. As tratamiento do espasmo e da contractura da hemifase pore infiltra con alcohólico. Acta AWHO 1996; 15(4):205-8.

  4. 4. Henderson JW. Essencial blephasrospasm. Trans Am Ophthalmol Soc 1956; 54:453-520.

  5. 5. Fahn S. The varied clinical expresions of dystonia Neurol Clinic 1984; 2:541-54.

  6. 6. Jankovic J, Ford J. Blepharoespasm and orofacial cervical dystonia. Clinical and pharmacologycal findings in 100 patients. Ann Neurol 1983; 13:402-11.

  7. 7. Marsden CD, Lang AE, Sheehy MP. Pharmacology of cranial dystonia (letter) Neurology 1983; 33:1100-1.

  8. 8. Scott AB, Kennedy RA, Stub HA. Botulinum A toxin injection as a treatment for Blepharospasm. Arch Ophthalmol 1985; 103:347-50.

  9. 9. Kraft SP, Lang AE. Cranial dystonia, Blepharoespasm and hemifacial spasm, clinical features and treatment including the use Botulinum toxin. Can Med Assoc J 1988; 139:837-44.

  10. 10. American Academy of Ophthalmology. Botulinum A toxin therapy of eye muscles disordes. Safety and effectiveness. Ophthalmology 1989; Book issue 37-41.

  11. 11. Taylor JDN, Kraft SP, Kazdan MS y col. Treatment of blepharoespasm and hemifacial spasm with Botulinum A Toxin. A Canadian multicentric study. Can J Ophthalmol 1991; 26:133-8.

  12. 12. Jannetta PJ, Abbasy M, Maroon JC y col. Etiology and definitive microsurgical treatment of hemifacial spasm. Operative techniques and results in 47 patients. J Neurosurg 1977; 47:321-8.

  13. 13. Arvizu Saldaña E, Vales Hidalgo O y col. Descompresión microvascular para el espasmo hemifacial, 10 años de experiencia. Arch Neurocien (Mex) 2004; 9(4): 189-194.




2020     |     www.medigraphic.com